Immunovant, Inc.
IMVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764013
In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Immunovant, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 181 | 1 | 228 | +48 |
| Shares | 66.9M | 5.99K | 68.4M | +1.52M (+2.3%) |
| Value | $2.57B | $230.0K | $2.88B | +$314.2M (+12.2%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (72)
Institutions that held Immunovant, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (24)
Institutions that held Immunovant, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Darwin Global Management, Ltd. | 1,818,371 | $69.8M |
| Fairmount Funds Management LLC | 750,000 | $28.8M |
| TCG Crossover Management, LLC | 334,853 | $12.9M |
| Cubist Systematic Strategies, LLC | 184,187 | $7.07M |
| Hennion & Walsh Asset Management, Inc. | 143,080 | $5.49M |
| Ghost Tree Capital, LLC | 130,000 | $4.99M |
| Alps Advisors Inc | 96,434 | $3.70M |
| Trexquant Investment LP | 77,806 | $2.99M |
| Virtu Financial LLC | 14,691 | $564.0K |
| Squarepoint Ops LLC | 14,587 | $560.0K |
| FORA Capital, LLC | 13,082 | $502.2K |
| Belvedere Trading LLC | 10,461 | $401.6K |
| Dark Forest Capital Management LP | 10,282 | $394.7K |
| Sigma Planning Corp | 7,965 | $305.8K |
| Corton Capital Inc. | 7,505 | $288.1K |
| Titleist Asset Management, LLC | 7,000 | $268.7K |
| Quantbot Technologies LP | 6,700 | $257.2K |
| Marshall Wace, LLP | 5,900 | $226.5K |
| Gotham Asset Management, LLC | 5,527 | $212.2K |
| Caption Management, LLC | 4,282 | $164.4K |
| Cutler Group LP | 900 | $34.0K |
| Glassman Wealth Services | 300 | $11.5K |
| PEAK6 Investments LLC | 89 | $3.42K |
| Harbour Investments, Inc. | 43 | $1.65K |
Not filed for Q4 2023 yet (1)
Institutions that held Immunovant, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| First Republic Investment Management, Inc. | 5,992 | $230.0K |